[Correspondence] A fundamental change is needed for appraising placebo responses in psychiatry

Click here for the article published by The Lancet Psychiatry.

In the Alpha-Stim Anxiety Insomnia and Depression cranial electrotherapy stimulation trial, Richard Morriss and colleagues reported no significant difference in their primary depression outcome between active and sham groups.1 Although not the headline of the article, 41% of recruited patients who received sham stimulation had remission of their depression. This remarkable result adds to the growing list of neurotechnology trials in psychiatry demonstrating very large responses in their placebo arms.

Continue reading ...

Disclaimer: The content of this article has not been checked or verified. Proceed at your own risk.

Back to Home Page

Leave a Comment

Your email address will not be published. Required fields are marked *

error: Alert: Content is protected !!